-- 分析师周三告诉,受中东冲突和美国生物燃料政策带来的整体能源市场强劲推动,豆油市场上涨可能还有进一步上涨的空间。 周二,豆油价格自2022年以来首次突破每磅72美分,本周也创下新高。 DTN分析师雷特·蒙哥马利表示,此次大幅上涨的基本原因是趋势性买盘,因为交易员对豆油需求前景依然非常看好,这得益于上个月美国环境保护署(EPA)出台的利好政策。 今年3月,EPA最终确定了可再生燃料标准“第二套”的最终规则,提高了2026年和2027年的生物燃料掺混配额,并将2023-2025年豁免的可再生燃料量义务重新分配至2026年和2027年的合规年度。 美国环保署 (EPA) 估计,为了达到 2026 年和 2027 年的历史性产量水平,生物柴油和可再生柴油的生产和使用量需要比 2025 年的水平增长 60% 以上。 美国油籽加工厂开发和运营公司 White River Nutrition 的联合创始人兼总裁 Walter Cronin 表示,大豆油价格上涨是由多方面因素推动的。 Cronin 说:“伊朗战争以及全球对各种燃料或生物燃料需求的飙升也是主要推动因素。” 近几个月来,大豆加工商注意到,大豆油的价格已经超过了豆粕的价格。 克罗宁表示:“豆油对利润的贡献率已在一段时间内维持在50%左右,这并非什么新变化。在RVO(可再生燃料油)第二阶段(2026年和2027年),豆油的贡献率很可能仍将维持在这一水平附近。” 分析师表示,豆油价格仍有上涨空间。克罗宁指出,只要生物柴油和可再生柴油的利润率保持盈利,且柴油价格持续飙升,豆油价格就可能进一步走高。 克罗宁说:“归根结底,燃料生产和豆油加工一样,都是利润导向型行业。只要生物柴油和可再生柴油行业有利可图,他们就会继续购买豆油作为原料。” 他还补充道,全球运费飙升这一事实也不容忽视。克罗宁表示:“因此,其他原料,例如进口废弃食用油,以美国交货价计算的价格正在大幅上涨,这使得国产燃料仅凭运费差价就具有原料优势。” 决策创新解决方案公司经济学家大卫·米勒表示,美国生物燃料政策的影响尚未完全反映在市场上。 米勒说:“原油和柴油价格的普遍上涨可能是近期豆油价格上涨的80%的原因,而生物燃料政策的影响约为20%。再生植物油(RVO)的影响可能尚未完全计入价格。随着再生植物油的影响被完全计入价格,豆油价格可能还会再上涨10%至20%。” 米勒表示,如果原油价格回落至每桶70美元左右,这将限制豆油价格的上涨。 “随着豆油价格上涨,食品用途中部分豆油将被其他油籽替代,例如菜籽油、葵花籽油和玉米油,”他说道。 美伊冲突扰乱了全球石油产品供应链,凸显了国内生物燃料政策的明智性。 “本质上,各国别无选择,正在迅速调整政策,以满足实际需求而非出于既定政策,”克罗宁说道。 他补充说,从此以后,全球对生物燃料的看法将发生永久性改变。各国将调整政策方向,提高生物燃料的纳入比例,并利用农业原料进行本地化生产。
Related Articles
Axis Bank's Consolidated Net Profit Rises in Fiscal Q4; Shares Down 3%
Axis Bank (NSE:AXISBANK, BOM:532215) consolidated net profit increased to 76.0 billion Indian rupees in the quarter ended March 31, against 74.8 billion rupees a year ago, according to a Saturday filing to the Indian stock exchanges.The banks' shares were down over 3% in Monday's trade.Earnings per share climbed to 24.33 rupees compared with the year-ago figure of 24.01 rupees.Interest earned by the lender in fiscal Q4 also grew year on year to 341.7 billion rupees from 324.5 billion rupees a year earlier.The board of directors recommended a dividend of 1 rupee per share for the financial year ended March 31.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Newmont Corporation
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target price by $3 to $153, assuming an EV/EBITDA of 7.0x our 2027 EBITDA estimate, above NEM's three-year average forward EV/EBITDA of 6.5x and above peers' 6.0x. We raise our 2026 EPS estimate by $1.67 to $10.31 and our 2027 EPS forecast by $2.09 to $12.89. Newmont remains on track to deliver its 2026 guidance of 5.3 million gold ounces, though management characterizes 2026 as a trough year due to planned mine sequencing at several operations. The company is well-positioned for production growth beginning in 2027, with a longer-term outlook of approximately 6 million ounces of gold and 150,000 tonnes of copper annually. Key growth drivers include completion of Tanami Expansion 2 (2H 2027), ongoing development of Cadia panel caves, and the Ahafo North ramp-up. NEM's world-class portfolio, coupled with robust free cash flow generation in a supportive gold price environment, supports sustained capital returns through its enhanced capital allocation framework.
Aye Finance's Consolidated Profit Jumps in Fiscal Q4; Shares Up 4%
Aye Finance's (NSE:AYE, BOM:544699) consolidated profit rose sharply to 859.1 million Indian rupees in the fiscal fourth quarter ended March 31, from 407.0 million rupees a year ago.The financial services company's earnings per share came in at 3.85 rupees from 2.09 rupees a year ago, according to a Monday filing to the Indian bourses.Revenue from operations in fiscal Q4 also increased to 5.28 billion rupees from 4.09 billion rupees a year ago.The company's shares were up over 4% in recent trade.